Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Ishida K, et al
A healthcare professional, such as a Midi clinician, will review your medical history and discuss any concerns you may have before prescribing a GLP-1 medication
No significant negative interactions have been documented between AOD-9604 and commonly used peptides
Immunogenicity: No Antibody Formation A critical safety consideration for any peptide therapy is immunogenicity, the potential to trigger immune system responses that could lead to allergic reactions, reduced efficacy through antibody neutralization, or autoimmune complications
Manufactured under controlled conditions, it is prepared to support reliable use within research environments
US$ 28.47
US$ 20.58
US$ 25.28
US$ 28.55
US$ 24.89
